WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 02
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 02

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 10  10  10  10  10  10 
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported cases

(Click for retrospective incidence data for Nauru)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  11  300  10 
Mumps
ChartChart
 
Pertussis
ChartChart
  166 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Nauru)
Vaccine year result method % card seen                                                
BCG 2006  98  DHS   95  99*  98  99*  99*  93 
DTP1 2006  98  DHS   95  98  80  98  99*  85 
DTP3 2006  89  DHS   95  91  75  79  99*  44 
DTP4          47  33 
IPV1          91  99* 
HepB_BD          99*  98  99*  99*  98 
HepB3          91  95  79  99*  58 
Hib3          91  75  79  99* 
JapEnc         
MCV1          98  65  96  99* 
MCV2          96  49  81  99* 
PCV1         
PCV3         
Pol3 2006  91  DHS   95  91  75  79  99*  27 
Rota1         
RotaC         
RCV1          98  65  96  99* 
TT2plus          24  99* 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Nauru)
BCG
ChartChart
  99  99  99  99  99  93  93 
DTP1
ChartChart
  98  99  99  98  99  85  90 
DTP3
ChartChart
  91  95  87  79  99  44  74 
HepB3
ChartChart
  91  95  87  79  99  58 
HepB_BD
ChartChart
  99  99  99  99  99  98 
Hib3
ChartChart
  91  95  87  79  99 
IPV1
ChartChart
  91 
MCV1
ChartChart
  98  98  97  96  99 
MCV2
ChartChart
  96  94  88  81  99 
PCV3
ChartChart
 
Pol3
ChartChart
  91  95  87  79  99  27  74 
RCV1
ChartChart
  98  98  97  96  99 
RotaC
ChartChart
 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 4 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric birth; Yes
IPV 14 weeks; Yes
MR 12, 15 months; Yes
OPV 6, 10, 14 week; 18 months; 4 years; Yes
TT 1st contact; +4 weeks; +6 months; No

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No    No  No  Yes  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number           14   

System performance

Total Nº districts in country number   14    14   
Nº districts with DTP3 coverage >=80% number          
% of districts with DTP3 coverage >=80% From 0 to 100%       100       
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100%            

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No    No  No  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No    No  No  Yes   

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100        NA    75 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No    No  No  No   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.